Nasopharyngeal Carcinoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Nasopharyngeal Carcinoma

What is the definition of Nasopharyngeal Carcinoma?
Nasopharyngeal carcinoma (NPC) is a tumor arising from the epithelial cells that cover the surface and line the nasopharynx.
What are the alternative names for Nasopharyngeal Carcinoma?
  • Nasopharyngeal carcinoma
  • Nasopharyngeal Cancer
Who are the top Nasopharyngeal Carcinoma Local Doctors?
Distinguished in Nasopharyngeal Carcinoma
Radiation Oncology
Distinguished in Nasopharyngeal Carcinoma
Radiation Oncology

TIROG - Swedish Cancer Institute - Radiosurgery Center

550 17th Avenue, Suite A10, 
Seattle, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Familial Prostate Cancer, Prostate Cancer, and Primitive Neuroectodermal Tumor (PNET). Dr. Landis is board certified in American Board Of Radiology. Dr. Landis is currently accepting new patients.

Elite in Nasopharyngeal Carcinoma
Elite in Nasopharyngeal Carcinoma
Department Of Head And Neck Surgery, 
Singapore, SG 

Melvin Chua practices practicing medicine in Singapore, Singapore. Mr. Chua is rated as an Elite expert by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Prostate Cancer, Mononucleosis, Prostatectomy, and Orchiectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Nasopharyngeal Carcinoma
Radiation Oncology | Otolaryngology
Elite in Nasopharyngeal Carcinoma
Radiation Oncology | Otolaryngology

Melanoma & Skin Cancer Center

1825 Fourth Street, Third Floor, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants. Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center. Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research. Dr. Yom is rated as an Elite provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Nasopharyngeal Carcinoma, Olfactory Neuroblastoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Merkel Cell Carcinoma. Dr. Yom is board certified in American Board Of Radiology, Radiation Oncology. Dr. Yom is currently accepting new patients.

What are the latest Nasopharyngeal Carcinoma Clinical Trials?
A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery

Summary: This phase II trial compares the effectiveness of cemiplimab with CDX-1140 to cemiplimab without CDX-1140 prior to surgery in treating patients with stage III-IV head and neck cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. CDX-1140 is a monoclonal antibo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer

Summary: This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to swallowing exercises to prevent future disease. Using blood tests to study cytokines (proteins related to the immune system) may help doctors learn if certain levels of cytokines affect whether or not side effects occur and if they put partic...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center